JPM19: Spark looks at scale, manufacturing as gene therapy matures

JPM19: Spark looks at scale, manufacturing as gene therapy matures

Source: 
Biopharma Dive
snippet: 

It was five years ago that Jeff Marrazzo, CEO of Spark Therapeutics, first stood in front of a crowd at the J.P. Morgan Healthcare Conference to outline his company's path forward. Fast forward to today, and the biotech is now a year removed from securing the first ever U.S. approval of a gene therapy for an inherited disease.